계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Kemia
company
About
Kemia is a drug discovery company based in San Diego, California.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $33.50M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Kémia operates as a pharmaceutical company. The company discovers and develops small molecule therapeutics. It offers allosteric kinase inhibitors for the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as for cardiovascular and metabolic conditions; and modulators of G protein-coupled receptors. The company specializes in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$33.50M
Kemia has raised a total of
$33.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 25, 2004 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 25, 2004 | Series B | $33.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Kemia is funded by 1 investors.
JP Morgan Chase
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
JP Morgan Chase
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
